Cardiology
From the Journals
Sports-related sudden cardiac arrest ‘extremely’ rare in women
Women have a significantly lower risk of suffering cardiac arrest during sports, which begs the question of risk-adapted screening in women,...
News
FDA expands evinacumab approval to younger kids with HoFH
The agency has okayed evinacumab-dgnb for patients aged 5-11 with homozygous familial hypercholesterolemia.
Commentary
What’s the ‘secret sauce’ to help patients move more?
When surveyed about aerobic exercise and strength training, only 24.6% meet weekly recommendations.
From the Journals
Factors linked with increased VTE risk in COVID outpatients
While the overall risk for VTE was low, age of at least 55 years, being male, and having a BMI of at least 30 and history of VTE increased the...
From the Journals
Treat together: Tackle heart disease and obesity simultaneously
A new review outlines how obesity can impair common imaging tests used to diagnose heart disease.
Conference Coverage
‘Unheard of’ PAH improvement with novel drug: STELLAR
Sotatercept, a designer molecule that removes a key driver of pulmonary arterial hypertension, had efficacy and safety in the first of three...
Commentary
A surfing PA leads an intense beach rescue
The rescue started with the PA beginning CPR on a man he found on the beach, who was blue in the face, had some secretions around his mouth, and...
Conference Coverage
Endurance exercise tied to more coronary atherosclerosis
Lifelong endurance athletes had more coronary plaques, including more noncalcified plaques, than fit and healthy individuals, according to a new...
From the Journals
Can SGLT2 inhibitors limit acute kidney injury in type 2 diabetes?
Contrary to the initial concerns that SGLT2 inhibitors might increase the risk of acute kidney injury, new data indicate that this complication is...
Conference Coverage
Wearable fluid sensor lowers risk of HF rehospitalizations: BMAD
By detecting elevated thoracic fluid levels, a wearable device improves management and outcomes of heart failure.
Conference Coverage
FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
In an in-hospital anticoagulation trial, the primary COVID endpoint was missed but a survival benefit is observed.